Skip to main content
. 2022 May 1;11(9):2548. doi: 10.3390/jcm11092548

Table 1.

Characteristics of women with and without PCOS.

Parameters PCOS; n = 60 Control Group; n = 15 p Value
Age [years] 24.0 (21.0; 29.0) 26.0 (22.0; 39.0) NS
BMI [kg/m2] 22.7 (19.7; 25.1) 23.7 (21.1; 25.4) NS
WHR 0.8 (0.76; 0.85) 0.8 (0.76; 0.82) NS
Fasting glucose [mg/dL] 88.0 (84.0; 90.0) 84.1 (81.0; 88.9) NS
Glucose after OGTT [mg/dL] 98.5 (86.0; 115.0) not assayed N/A
Fasting insulin [mU/mL] 6.0 (3.6; 8.9) 6.4 (5.2; 9.0) NS
Insulin after OGTT [mU/mL] 27.4 (17.8; 47.7) not assayed N/A
HOMA-IR 1.3 (0.8; 1.9) 1.3 (1.1; 2.0) NS
Total cholesterol (mg/dL) 167.5 (148.0; 190.0) 179.0 (167.0; 207.0) NS
LDL-C (mg/dL) 92.0 (78.0; 113.0) 107.0 (84.0; 127.0) NS
HDL-C (mg/dL) 55.0 (46.0; 65.0) 58.0 (54.0; 74.0) NS
Triglycerides (mg/dL) 73.5 (59.5; 118.0) 84.0 (62.0; 122.0) NS
SOD1 activity [U/L] 5.1 (4.5; 6.0) 9.1 (5.5; 9.9) <0.001
Zn [µg/L] 857.0 (755.6; 931.5) 946.3 (877.7; 1066.3) <0.001
Cu [µg/L] 848.6 (746.9; 1009.8) 1195.2 (1164.1; 1336.4) <0.001
Cu/Zn ratio 1.0 (0.9; 1.1) 1.3 (1.1; 1.4) <0.001

Legend: Values shown as median (1st quartile, 3rd quartile); PCOS—polycystic ovary syndrome; BMI—body mass index, WHR—waist-to-hip ratio, OGTT—oral glucose tolerance test; HOMA-IR—homeostatic model assessment for insulin resistance; LDL-C—low-density lipoprotein; HDL-C—high-density lipoprotein; SOD—superoxide dismutase; Zn—zinc; Cu—copper; N/A—not applicable; NS—not significant.